How Some Generic Drugs Could Do More Harm Than Good
For the 16 years that Dr. Brian Westerberg, a Canadian surgeon, worked volunteer missions at the Mulago National Referral Hospital in Kampala, Uganda, scarcity was the norm. The patients usually exceeded the 1,500 allotted beds. Running water was once cut off when the debt-ridden hospital was unable to pay its bills. On some of his early trips, Westerberg even brought over drugs from Canada in order to treat patients. But as low-cost generics made in India and China became widely available through Uganda’s government and international aid agencies in the early 2000s, it seemed at first like the supply issue had been ...
Source: TIME: Health - May 17, 2019 Category: Consumer Health News Authors: Katherine Eban Tags: Uncategorized generic drugs medication medicine Source Type: news
Metoprolol vs. losartan
Title: Metoprolol vs. losartanCategory: MedicationsCreated: 5/14/2019 12:00:00 AMLast Editorial Review: 5/14/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 14, 2019 Category: Drugs & Pharmacology Source Type: news
More Losartan Joins Recall List, Heritage Pharma Distributors More Losartan Joins Recall List, Heritage Pharma Distributors
Manufacturer Vivimed has recalled 19 lots of its losartan potassium found with the same potential carcinogen that has led to recalls of both losartan and valsartan from various companies.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 6, 2019 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news
More Tainted Losartan With Ties to Hetero Labs Recalled More Tainted Losartan With Ties to Hetero Labs Recalled
Teva Pharmaceuticals is just the latest company this month to recall losartan products after detecting nitrosamines in the active pharmaceutical ingredient made by Hetero.News Alerts (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - April 30, 2019 Category: Neurology Tags: Cardiology News Alert Source Type: news
Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan
Find out which specific blood pressure medications are affected by the recall (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
More Questions and Answers: Impurities Found in Certain Angiotensin II Receptor Blocker (ARB) products
Answers to questions about nitrosamine impurities found in valsartan, losartan, and irbesartan and FDA's actions to address the issue (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Recalls of Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan
Get current information about recalls of blood pressure medications: valsartan, losartan, and irbesartan (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)
Get updates on the recalls (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
FDA provides update on ongoing investigation into ARB drugs; new losartan recall announced (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 27, 2019 Category: American Health Authors: FDA Source Type: news
Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply
Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 26, 2019 Category: Food Science Source Type: news
Legacy Pharmaceutical Expands Losartan Recall Legacy Pharmaceutical Expands Losartan Recall
The repackaged lot was distributed nationwide and tied to a larger recall of losartan announced just days ago.News Alerts (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 25, 2019 Category: Cardiology Tags: Cardiology News Alert Source Type: news
Legacy Pharmaceutical Packaging, LLC Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)
Legacy Pharmaceutical Packaging, LLC is expanding its consumer-level recall of 3 repackaged lots Losartan Tablets USP 50mg to include one additional lot. (Source: Food and Drug Administration)
Source: Food and Drug Administration - April 25, 2019 Category: Food Science Source Type: news
Torrent Pharma recalls over 10.78 lakh bottles of hypertension drug from US
The US-based arm of Torrent Pharmaceuticals is recalling 133,992 bottles of Losartan Potassium tablets USP in the strength of 25 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 20, 2019 Category: Pharmaceuticals Source Type: news
Recall of blood pressure drug losartan expanded
If you take blood pressure medicine, you'll want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. (Source: CNN.com - Health)
Source: CNN.com - Health - April 19, 2019 Category: Consumer Health News Source Type: news
Recall Of Blood Pressure Drug Losartan Expanded
(CNN) — If you take blood pressure medicine, you’ll want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets.
Tests found trace amounts of a potentially cancer-causing impurity called N-methylnitrosobutyric acid in some of these drugs. The company is recalling 36 additional lots, it said Thursday.
A full list of recalled drugs is available on the US Food and Drug Administration website.
Some of the recalled blood pressure medication (Image credit: FDA)
The company hasn’t had any reports of users getting ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 19, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News losartan Source Type: news
